Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

2 recruiting1 with results

Enrollment Performance

Analytics

N/A

5(71.4%)

Phase 2

1(14.3%)

Phase 1

1(14.3%)

7Total

N/A(5)

Phase 2(1)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT03170440Not ApplicableRecruiting

Non-invasive Nerve Stimulation for PTSD and Sleep

Role: collaborator

NCT04460872Phase 2Recruiting

Locomotor Training With Testosterone to Promote Bone and Muscle Health After Spinal Cord Injury

Role: collaborator

NCT03022669Not ApplicableUnknown

Mobile Health Strategies for Veterans

Role: collaborator

NCT02294175Not ApplicableCompleted

Larval Debridement Therapy Versus Sharp Debridement to Remove Biofilm

Role: collaborator

NCT03256500Not ApplicableUnknown

Transcranial Direct Current Stimulation for the Treatment of Delirium

Role: lead

NCT00746759Completed

Airway Epithelium Gene Expression: AEGIS IDE

Role: collaborator

NCT00322699Phase 1Completed

Sequential Whole Bladder Photodynamic Therapy (WBPDT) in the Management of Superficial Bladder Cancer

Role: lead

NCT00382356Not ApplicableCompleted

Dutasteride After Failure of Finasteride In the Management of Symptomatic Prostatic Enlargement/Hypertrophy (BPE/H)

Role: lead

All 8 trials loaded